SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNostra Terra Regulatory News (NTOG)

  • There is currently no data for NTOG

Q3 Production and Operations Update

30 Dec 2022 07:00

RNS Number : 2510L
Nostra Terra Oil & Gas Company PLC
30 December 2022
 

30 December 2022

 

Nostra Terra Oil and Gas Company Plc

("Nostra Terra" or "the Company")

 

Q3 Production and Operations Update

 

Nostra Terra (AIM: NTOG), the international oil & gas exploration and production company with a portfolio of development and production assets in Texas, USA, is pleased to provide a production and operations update for the Company for Q3 2022.

 

Highlights

 

· On track for record annual production and revenue

· 25% sales growth from start of the year

· 2nd consecutive quarter with revenue in excess of $1,000,000

 

Production

During the third quarter net sales were 11,568 barrels (100% oil) resulting in $1,042,704 of revenue with the average realised sales price for the period being $90.14 per barrel. Production volumes were higher in Q3 22 than Q2 22, which were in turn higher than in Q1 22.

 

Production (Sales) - Bbls

$USD

Gross 

(Monthly)

NTOG - Net (Monthly)

NTOG - Net

(Daily)

NTOG Net Revenue

January 2022

6,105

3,531

114

$265,254

February 2022

3,649

1,759

63

$149,867

March 2022

7,277

3,833

124

$446,381

Q1-22 TOTAL

17,031

9,123

101

$861,502

April 2022

6,726

3,510

117

$313,382

May 2022

9,960

4,116

133

$437,490

June 2022

9,108

3,634

121

$390,867

Q2-22 TOTAL

25,795

11,260

124

$1,141,739

July 2022

10,658

4,281

138

$421,986

August 2022

9,396

3,422

110

$310,005

September 2022

10,314

3,865

116

$310,713

Q3-22 TOTAL

30,368

11,568

126

$1,042,704

 

Sales figures are based on an accruals basis and may vary slightly from actuals.

 

Operations

 

Production for the Quarter increased slightly over the prior quarter. A number of wells were shut-in during the period, whilst planned production facility improvement was undertaken at the Pine Mills field (where the Company holds a 100% working interest).

 

Facility upgrades at Pine Mills have now been completed with treating and disposal capacity approximately doubled, while decreasing injection pressure by approximately 50%. Previously shut-in wells will be returned to production during Q4 as treating capacity expansion is brought online.

 

The Fouke 1 production increased by approximately 24% following upgrades to the pumping unit. Both the Fouke 1 and Fouke 2 wells are now on electric power, decreasing operation costs, thus improving margins. 

 

Matt Lofgran, Nostra Terra's Chief Executive Officer, said:

 

"Company-wide production remains robust, with quarterly sales surpassing $1 million for the second consecutive quarter. Despite having several wells down for the period, during the planned facility improvements at Pine Mills, we still managed a slight increase in production.

 

The Company continues to grow its production and revenue using only internal resources, while reducing its leverage. This provides the Company with increased flexibility on how to grow going forward.

 

We're on track for a record year and I look forward to reporting on these results in subsequent periods."

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

For further information, contact:

Nostra Terra Oil and Gas Company plc

Matt Lofgran, CEO

 

Tel:

+1 480 993 8933

Beaumont Cornish Limited

(Nominated Adviser)

James Biddle/ Roland Cornish

 

Tel:

+44 (0) 20 7628 3396

Novum Securities Limited (Broker)

Jon Belliss

 

Lionsgate Communications (Public Relations)

Jonathan Charles

Tel:

 

Tel:

 

+44 (0) 207 399 9425

 

 +44 (0) 7791 892509

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DRLBLBDDSUDDGDC
Date   Source Headline
26th Jun 20257:00 amRNSChange of Name
20th Jun 202510:40 amRNSResults of Annual General Meeting
3rd Jun 20257:00 amRNS-REngage Investor Presentation
23rd May 20257:00 amRNS2024 Audited Annual Results & Notice of AGM
3rd Apr 20257:00 amRNSPartner Approval for Fouke 3 Well
17th Mar 20257:00 amRNS-REngage Investor Presentation
11th Mar 20257:00 amRNSHolding(s) in Company
4th Mar 20257:00 amRNSCompletion of £500,000 Fundraise
24th Feb 20257:00 amRNSProduction and Operations Update
11th Feb 202512:57 pmRNSHolding(s) in Company
29th Jan 20257:00 amRNS3-Year Renewal of Senior Lending Facility
23rd Jan 20257:00 amRNSHolding(s) in Company
21st Jan 202512:29 pmRNSHolding(s) in Company
21st Jan 20257:05 amRNSIncreased Holdings in the Company
21st Jan 20257:00 amRNSProduction and Operations Update
2nd Jan 20257:00 amRNSBoard Change
27th Dec 20244:35 pmRNSHolding(s) in Company
27th Dec 20247:00 amRNSHolding(s) in Company
28th Nov 202412:15 pmRNSHolding(s) in Company
21st Nov 20247:00 amRNSFundraise to increase production & cash flow
12th Nov 20244:48 pmRNSHolding(s) in Company
11th Nov 20247:00 amRNSProduction and Operations Update
20th Sep 202411:50 amRNSShare Issuance
20th Sep 20247:00 amRNSShare Issuance
19th Sep 20247:00 amRNSInterim Results for six months ended 30 June 2024
6th Sep 20247:00 amRNSChange of Nominated Adviser
29th Aug 202412:30 pmRNSHolding(s) in Company
27th Aug 202412:41 pmRNSHolding(s) in Company
22nd Aug 20244:54 pmRNSHolding(s) in Company
20th Aug 202412:15 pmRNSHolding(s) in Company
19th Aug 20243:52 pmRNSHolding(s) in Company
16th Aug 20244:45 pmRNSHolding(s) in Company
16th Aug 20247:00 amRNSHolding(s) in Company
14th Aug 20244:56 pmRNSHolding(s) in Company
13th Aug 20247:00 amRNSHolding(s) in Company
7th Aug 202411:52 amRNSHolding(s) in Company
2nd Aug 20244:28 pmRNSDirector Increases Participation in Fundraise
29th Jul 20247:00 amRNS£450,000 Fundraise aimed at increasing production
17th Jul 202411:08 amRNSAdvisor Change
17th Jul 202410:13 amRNSResult of Meeting
1st Jul 20245:00 pmRNSCorporate Update & Notice of General Meeting
27th Jun 20242:46 pmRNSResult of AGM
27th Jun 20247:00 amRNSAppointment of Non-Executive Director
13th Jun 20247:00 amRNSProposed Appointment of Non-Executive Director
31st May 20247:00 amRNSFinal Results
20th May 20248:01 amRNSBoard Changes
22nd Feb 20247:00 amRNSHolding(s) in Company
6th Feb 20249:23 amRNSHolding(s) in Company
30th Jan 20249:37 amRNSHolding(s) in Company
30th Jan 20249:34 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.